An Index of the Value in Large Cap PharmaCos’ Mid- to Early-Stage Pipelines

Summary and Investment Conclusion Capital markets can see the characteristics of, and thus place reasonable values on, drug products that are on-market, in registration, or in very late (phase III)…

Continue ReadingAn Index of the Value in Large Cap PharmaCos’ Mid- to Early-Stage Pipelines